https://www.selleckchem.com/products/zn-c3.html
MATCH was a randomized, double-blind, placebo-controlled study enrolling Japanese and Korean men aged ≥ 40years who still had overactive bladder (OA symptoms while receiving tamsulosin. After a 4-week single-blind screening period in which patients received placebo and tamsulosin, patients were randomized to mirabegron 50mg + tamsulosin or placebo + tamsulosin for 12weeks (n = 568). This post hoc analysis investigated the proportion of treatment responders for each treatment group and for subgroups stratified by age based on voiding dia
Like
Comment
Share
